VEA

Virtus ETF Advisers Portfolio holdings

AUM $75.7M
1-Year Return 23.01%
This Quarter Return
-0.88%
1 Year Return
+23.01%
3 Year Return
+79.79%
5 Year Return
+153.94%
10 Year Return
–
AUM
$227M
AUM Growth
-$15.9M
Cap. Flow
-$6.79M
Cap. Flow %
-2.99%
Top 10 Hldgs %
7.9%
Holding
407
New
8
Increased
60
Reduced
329
Closed
10

Top Buys

1
XFLT
XAI Octagon Floating Rate and Alternative Income Trust
XFLT
$663K
2
VTA
INVESCO DYNAMIC CREDIT OPPORTUNITIES FUND
VTA
$551K
3
FRA icon
BlackRock Floating Rate Income Strategies Fund
FRA
$469K
4
EFT
Eaton Vance Floating-Rate Income Trust
EFT
$425K
5
ENIC icon
Enel Chile
ENIC
$406K

Top Sells

1
GRA
W.R. Grace & Co.
GRA
$1.73M
2
BGX
Blackstone Long-Short Credit Income Fund
BGX
$731K
3
BGB
Blackstone Strategic Credit 2027 Term Fund
BGB
$693K
4
NOA
North American Construction
NOA
$569K
5
MCI
Barings Corporate Investors
MCI
$524K

Sector Composition

1 Healthcare 25.28%
2 Real Estate 19.7%
3 Energy 13.28%
4 Utilities 12%
5 Materials 10.51%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
CRNX icon
226
Crinetics Pharmaceuticals
CRNX
$3.35B
$236K 0.1%
11,225
-585
-5% -$12.3K
KLRS
227
Kalaris Therapeutics, Inc. Common Stock
KLRS
$86.4M
$235K 0.1%
407
-21
-5% -$12.1K
ANAB icon
228
AnaptysBio
ANAB
$613M
$232K 0.1%
8,537
-450
-5% -$12.2K
APLS icon
229
Apellis Pharmaceuticals
APLS
$3.55B
$232K 0.1%
7,052
-641
-8% -$21.1K
NGM
230
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
$230K 0.1%
10,924
-577
-5% -$12.1K
ALEC icon
231
Alector
ALEC
$305M
$229K 0.1%
10,039
-517
-5% -$11.8K
CDXS icon
232
Codexis
CDXS
$218M
$229K 0.1%
9,865
-520
-5% -$12.1K
TVRD
233
Tvardi Therapeutics, Inc. Common Stock
TVRD
$292M
$229K 0.1%
411
-22
-5% -$12.3K
CUE icon
234
Cue Biopharma
CUE
$59.9M
$228K 0.1%
15,636
-812
-5% -$11.8K
FIV
235
DELISTED
First Trust Senior Floating Rate 2022 Target Term Fund Common Shares of Beneficial Interest
FIV
$228K 0.1%
23,625
-2,605
-10% -$25.1K
EDIT icon
236
Editas Medicine
EDIT
$248M
$227K 0.1%
5,518
-288
-5% -$11.8K
IMTX icon
237
Immatics
IMTX
$761M
$227K 0.1%
17,438
-912
-5% -$11.9K
QTTB icon
238
Q32 Bio
QTTB
$20.4M
$226K 0.1%
1,599
-83
-5% -$11.7K
CCCC icon
239
C4 Therapeutics
CCCC
$194M
$225K 0.1%
5,043
-269
-5% -$12K
ORIC icon
240
Oric Pharmaceuticals
ORIC
$1.06B
$225K 0.1%
10,782
-567
-5% -$11.8K
GRTS
241
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
$225K 0.1%
20,837
-1,093
-5% -$11.8K
MRTX
242
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$221K 0.1%
1,249
-69
-5% -$12.2K
NKTX icon
243
Nkarta
NKTX
$161M
$220K 0.1%
7,921
-416
-5% -$11.6K
VKTX icon
244
Viking Therapeutics
VKTX
$3.03B
$220K 0.1%
34,971
-1,820
-5% -$11.4K
IOVA icon
245
Iovance Biotherapeutics
IOVA
$901M
$219K 0.1%
8,901
-470
-5% -$11.6K
SRRK icon
246
Scholar Rock
SRRK
$3.02B
$219K 0.1%
6,624
-351
-5% -$11.6K
MYOV
247
DELISTED
Myovant Sciences Ltd.
MYOV
$219K 0.1%
9,755
-515
-5% -$11.6K
AGEN
248
Agenus
AGEN
$138M
$217K 0.1%
2,107
-110
-5% -$11.3K
NRIX icon
249
Nurix Therapeutics
NRIX
$758M
$216K 0.1%
7,193
-377
-5% -$11.3K
ALLO icon
250
Allogene Therapeutics
ALLO
$255M
$215K 0.09%
8,379
-438
-5% -$11.2K
8 9
10
11 12